About
About
Contact Us
Pipeline
Pipeline
Sirexatamab (DKN-01) Programs
Gastric Cancer
Colorectal Cancer
Endometrial Cancer
Prostate Cancer
Lung Cancer
FL-301 (NBL-015) Program
FL-501 Program
Science
Science
DKK1
Sirexatamab (DKN-01)
Claudin18.2
GDF-15
Patients
Patients
Expanded access
Careers
Investors
Investors
Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request
Science
The role of
DKK1
in cancer
MORE ABOUT SIREXATAMAB (DKN-01):
Sirexatamab (DKN-01)
–
an anti-DKK1 antibody
The role of
Claudin18.2
in cancer
VIEW PROGRAM
FL-301 (NBL-015)
The role of
GDF-15
in cancer
VIEW PROGRAM
FL-501